DOVA PHARMACUET Revenue, Profits - DOVA Quarterly Income Statement

Add to My Stocks
$23.95 $0.68 (2.76%) DOVA stock closing price Sep 21, 2018 (Closing)

Stock analysis based on fundamentals means looking at financial statements in addition to the DOVA PHARMACUET stock price. In the income statement, an investor can check for important parameters like the topline or sales, the bottomline or profits, the basic EPS, dividends etc. The income statement is always for an accounting period, typically for a year or quarter, and affects the stock. In this case, the DOVA stock is bound to reflect the impact of the QOQ growth of 0. The operating expenses as shown in the DOVA PHARMACUET profit and loss statement for 2018 Q2 total to $23.06M. This line item shows that the operating expenses has increased compared with last year. Also check: DOVA PHARMACUET assets and DOVA PHARMACUET free cash flow.

View and download details of revenue and profits for DOVA PHARMACUET for latest & last 40 quarters.
show more
Quarterly
Annual
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec2018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q32016 Q2
DOVA PHARMACUET Revenues or Net Sales
4.58M-------
Cost Of Goods Sold (COGS)--------
DOVA PHARMACUET Gross Profit
4.06M-------
Research & Development Expense4.5M3.41M2.73M5.42M3.29M4.27M6.75M6.99M
Selling General & Admin Expense18.56M10.26M6.46M4.18M1.9M---
Income Before Depreciation Depletion Amortization-19M-13.67M-9.17M-9.61M-5.19M-5.23M-7.12M-7.25M
Depreciation Depletion Amortization--------
Non Operating Income-0.19M----0.01M--0.01M-
Interest Expense--------
DOVA PHARMACUET Pretax Income
-19.65M-13.77M-9.31M-9.72M-5.5M-5.42M-7.17M-7.25M
Provision for Income Taxes--------
MinorityInterest--------
Investment Gains Losses--------
Other Income--------
Income Before Extraordinaries & Disc Operations-19.66M-13.77M-9.3M-9.72M-5.51M-5.42M-7.17M-7.25M
Extraordinary Items & Discontinued Operations--------
DOVA PHARMACUET Profit/ Loss (Net Income)
-19.66M-13.77M-9.3M-9.72M-5.51M-5.42M-7.17M-7.25M
Average Shares used to compute Diluted EPS28.19M26.59M25.65M25.29M17.33M---
Average Shares used to compute Basic EPS28.19M26.59M25.65M25.29M17.33M---
Income Before Nonrecurring Items-19.66M-13.77M-9.3M-9.72M-5.51M---
Income from Nonrecurring Items--------
DOVA PHARMACUET Earnings Per Share Basic Net
-0.70-0.52-0.36-0.38-0.32---
DOVA PHARMACUET Earnings Per Share Diluted Net
-0.70-0.52-0.36-0.38-0.32---
EPS Diluted Before Nonrecurring Items-0.70-0.52-0.36-0.38-0.32---
Preferred Dividends Acc Pd--------
Dividends Common0.000.000.00-----
Dividend Per Share Common0.000.000.000.000.000.000.000.00
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters

DOVA PHARMACUET stock analysis involves checking at least a few of the important things like:

  • Revenue: This is the inflow that is generated from the sale of goods or services and is $4.58M for this quarter of 2018 Q2. Our DOVA PHARMACUET revenue chart gives a clear visual representation of how the topline or sales growth has been. Investors often invest only in those companies where the revenue is growing at a steady rate.
  • Bottom line: Most businesses like DOVA PHARMACUET try to grow their profits by growing their topline and by increasing their operating efficiency. A healthy bottom line growth implies a good investment.

The income statement is also called the profit and loss statement. Apart from the DOVA income statement, one can check the DOVA PHARMACUET historical stock prices to check how the price has moved with time.

DOVA PHARMACUET Income Statement - Key Financial Ratios

Other Income Statements - DOVA PHARMACUET Industry Peers

Sagent Pharma income statement